Here are the worst-performing U.S. stocks on Tuesday
Provided by Dow Jones
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Provided by Business Wire
Astellas Announces the Approval of XTANDI® (enzalutamide) by the China National Medical Products Administration (NMPA)
Provided by PR Newswire
Akcea, Ionis Close Licensing Agreement with Pfizer on New Drug
Provided by Dow Jones
Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)
Provided by GlobeNewswire
Pfizer: FDA Approves Humira Biosimilar Abrilada for Multiple Conditions
Provided by Dow Jones
FDA Approves Pfizer’s Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions
Provided by Business Wire
Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals
Provided by Business Wire
CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.
Provided by GlobeNewswire
Mylan and Pfizer Say Combined Mylan-Upjohn to Be Called Viatris
Provided by Dow Jones